Delivery Order SPE2DB20D1051-SPE2DB25FD7XE

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml Suspension, a pharmaceutical product, with a ceiling value of $18,234.82. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,076.20, is for the delivery of the pharmaceutical product Nitrofurantoin 25 mg/5 ml suspension in 240 ml bottles. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 8, 2024. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $15,539.37 firm fixed price delivery order is for the supply of 240 mL bottles of Nitrofurantoin 25 mg/5 mL suspension medication. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical through November 2026, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nitrofurantoin 25 mg/5 ml suspension. The $6,848.83 firm-fixed-price contract has a period of performance through May 4, 2022. The contract was awarded on May 3, 2022 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $32,537.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml suspension, a pharmaceutical product, with a performance period ending on March 26, 2024. The contract is a firm fixed price delivery order, with no set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,946.65 firm-fixed-price contract is for the delivery of 240 ml bottles of the antibiotic drug Nitrofurantoin 25 mg/5 ml suspension. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The contract has a ceiling value of $1,287.37 and a period of performance through March 7, 2025. This is a firm fixed price delivery order contract, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,018.27, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, with a performance period ending on March 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award, valued at $7,824.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a completion date of December 18, 2023. This is a firm fixed-price delivery order contract, and it is not designated as a set-aside requirement. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,757.64 firm fixed-price delivery order contract is for the supply of 230 ml bottles of 25 mg/5 ml Nitrofurantoin suspension, a medication used to treat urinary tract infections. The contract has a completion date of July 16, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB25FD7XE
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml suspension with a ceiling value of $3,033.72. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/29/25, 9:49 AM